Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Oncosynergy Inc.
Headquarters: San Francisco, CA, United States of America
Website: http://www.oncosynergy.com
Year Founded: 2011
Status: Private
BioCentury | May 18, 2023
Management Tracks
Roche’s Perettie to head cell therapy at Kite
Plus: Ochre appoints Forster as chairperson and updates from Women In Bio, Verismo and MIG
BioCentury | Jul 28, 2016
Distillery Therapeutics
Therapeutics: Integrin β1 (CD29); c-Met receptor tyrosine kinase (c-MET; MET; HGFR; c-Met proto-oncogene)
BioCentury | Jun 16, 2014
Emerging Company Profile
OncoSynergy: Detoxing its target
OncoSynergy designs OS2966 to safely inhibit integrin beta(1) for brain cancer
Items per page:
1 - 5 of 5